Quantcast

Latest Thrombosis Stories

2014-03-24 08:28:21

Presentations to include research around antidote for dabigatran, a post-hoc analysis of data from the RE-LY® trial and data from the GLORIA(TM)-AF registry RIDGEFIELD, Conn., March 24, 2014

2014-03-24 08:27:40

- Subgroup analyses of East Asian populations from two phase 3 studies, ENGAGE AF-TIMI 48 and Hokusai-VTE, showed consistent results compared to the global study populations from these trials(1,2,3,4) TOKYO,

2014-03-24 08:26:49

Results Show Highest Rate of Control Ever Observed with Warfarin in Real-world Setting, Surpassing Thresholds for Cost-Effectiveness of Newer Agents Identified in Five Recent Independent Studies

2014-03-20 00:21:35

Insufficient medical care of blood clots in the extremities is prevalent, but Dr.

2014-03-03 23:02:09

Despite the FDA's recent rejection of Xarelto, Dr.

2014-02-26 23:02:53

The Firm is investigating testosterone treatment lawsuits on behalf of men who suffered heart attacks, strokes, deep vein thrombosis, pulmonary embolism, or other serious cardiovascular problems,

2014-02-19 23:02:44

The Firm is evaluating testosterone treatment lawsuits on behalf of individuals who allegedly suffered heart attacks, strokes, deep vein thrombosis, and pulmonary embolism due to their use of

2014-02-14 08:26:09

RARITAN, N.J., Feb. 14, 2014 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen) announced today the U.S.

2014-01-08 12:30:25

Submission based on the two largest comparative phase 3 clinical trials of a novel oral anticoagulant in patients with non-valvular atrial fibrillation or symptomatic venous thromboembolism TOKYO


Word of the Day
swell-mobsman
  • A member of the swell-mob; a genteelly clad pickpocket. Sometimes mobsman.
Use of the word 'swell-mobsman' dates at least to the early 1800s.